Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-Current Debt: 2023-2024

Historic Non-Current Debt for OptimizeRx (OPRX) over the last 2 years, with FY2024 value amounting to $30.8 million.

  • OptimizeRx's Non-Current Debt fell 2547.33% to $24.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year decrease of 2547.33%. This contributed to the annual value of $30.8 million for FY2024, which is 997.63% down from last year.
  • Per OptimizeRx's latest filing, its Non-Current Debt stood at $30.8 million for FY2024, which was down 997.63% from $34.2 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Non-Current Debt registered a high of $34.2 million during FY2023, and its lowest value of $30.8 million during FY2024.